US TO BUY 1.7 MILLION COURSES OF MERCK’S COVID PILL
Wed 09 June 2021: The United States on Wednesday announced an agreement with Merck to buy 1.7 million courses of an experimental antiviral pill against Covid-19. The $1.2 billion Dollar deal is for a drug called molnupiravir, which is currently being tested in a global Phase 3 clinical trial of 1,850 people, with results expected […]
Continue Reading
